Inside Nephrology: A Weekly Review
Nefrologia
Kidney Disease and Heart Failure: The Bidirectional Relationship
Exploring the complex relationship between kidney and heart disease, featuring recent research on therapeutic strategies, renal denervation, and novel treatments like molecular hydrogen.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. Kidney disease and heart failure: recent advances and current challenges: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Authors: Lam CSP, Bozkurt B, Cherney DZI, et al.
Journal: Kidney international, 2026 Jun
PMID: 41791738
DOI: 10.1016/j.kint.2025.10.011
2. Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reports.
Authors: Mahfoud F, Kandzari DE, Schlaich MP, et al.
Journal: European journal of preventive cardiology, 2026 May 15
PMID: 40676971
DOI: 10.1093/eurjpc/zwaf368
3. Meta Analysis of DHA and EPA Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk.
Authors: Shayan SK, Abbood RS, Al-Taie SF, et al.
Journal: Pharmacology research & perspectives, 2026 Jun
PMID: 42144851
DOI: 10.1002/prp2.70265
4. Molecular hydrogen and kidney diseases: a scoping review based on scientometry and data analytics.
Authors: Viana J, Castro C, Leiva V
Journal: Medical gas research, 2026 Jun 1
PMID: 40826940
DOI: 10.4103/mgr.MEDGASRES-D-25-00047
5. Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial.
Authors: Hamatani Y, Claggett BL, Kulac IJ, et al.
Journal: European journal of heart failure, 2026 May 11
PMID: 41771106
DOI: 10.1093/ejhf/xuag030
6. CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.
Authors: Schnell O, Agarwal A, Azizi M, et al.
Journal: Cardiovascular diabetology, 2026 May 6
PMID: 42092956
DOI: 10.1186/s12933-026-03140-0
7. Hot topics in the antiphospholipid syndrome.
Authors: Fujieda Y, Amengual O, Meroni PL, et al.
Journal: Current opinion in immunology, 2026 Jun
PMID: 41990480
DOI: 10.1016/j.coi.2026.102775
8. Vitamin B(12) Supplementation: Is More Always Better?
Authors: Yepes-Calderón M, Doorenbos CSE, Stegmann ME, et al.
Journal: Nutrients, 2026 May 18
PMID: 42197057
DOI: 10.3390/nu18101597
9. Update in clinical science: MASLD in children and adolescents.
Authors: Lefere S, Koot BGP, Mann JP, et al.
Journal: Journal of hepatology, 2026 Jun
PMID: 41730387
DOI: 10.1016/j.jhep.2026.02.016
10. Deleterious variants in LTBP4 are associated with severe pediatric sepsis.
Authors: Qin Y, Kernan KF, Bai Y, et al.
Journal: Pediatric research, 2026 Jun
PMID: 41076474
DOI: 10.1038/s41390-025-04420-3
Authors: Lam CSP, Bozkurt B, Cherney DZI, et al.
Journal: Kidney international, 2026 Jun
PMID: 41791738
DOI: 10.1016/j.kint.2025.10.011
2. Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reports.
Authors: Mahfoud F, Kandzari DE, Schlaich MP, et al.
Journal: European journal of preventive cardiology, 2026 May 15
PMID: 40676971
DOI: 10.1093/eurjpc/zwaf368
3. Meta Analysis of DHA and EPA Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk.
Authors: Shayan SK, Abbood RS, Al-Taie SF, et al.
Journal: Pharmacology research & perspectives, 2026 Jun
PMID: 42144851
DOI: 10.1002/prp2.70265
4. Molecular hydrogen and kidney diseases: a scoping review based on scientometry and data analytics.
Authors: Viana J, Castro C, Leiva V
Journal: Medical gas research, 2026 Jun 1
PMID: 40826940
DOI: 10.4103/mgr.MEDGASRES-D-25-00047
5. Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial.
Authors: Hamatani Y, Claggett BL, Kulac IJ, et al.
Journal: European journal of heart failure, 2026 May 11
PMID: 41771106
DOI: 10.1093/ejhf/xuag030
6. CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.
Authors: Schnell O, Agarwal A, Azizi M, et al.
Journal: Cardiovascular diabetology, 2026 May 6
PMID: 42092956
DOI: 10.1186/s12933-026-03140-0
7. Hot topics in the antiphospholipid syndrome.
Authors: Fujieda Y, Amengual O, Meroni PL, et al.
Journal: Current opinion in immunology, 2026 Jun
PMID: 41990480
DOI: 10.1016/j.coi.2026.102775
8. Vitamin B(12) Supplementation: Is More Always Better?
Authors: Yepes-Calderón M, Doorenbos CSE, Stegmann ME, et al.
Journal: Nutrients, 2026 May 18
PMID: 42197057
DOI: 10.3390/nu18101597
9. Update in clinical science: MASLD in children and adolescents.
Authors: Lefere S, Koot BGP, Mann JP, et al.
Journal: Journal of hepatology, 2026 Jun
PMID: 41730387
DOI: 10.1016/j.jhep.2026.02.016
10. Deleterious variants in LTBP4 are associated with severe pediatric sepsis.
Authors: Qin Y, Kernan KF, Bai Y, et al.
Journal: Pediatric research, 2026 Jun
PMID: 41076474
DOI: 10.1038/s41390-025-04420-3
